Cantitate/Preț
Produs

Opium: Little Books (Ronin Publishing)

Autor Francis Moraes, Debra Kita, Debra Moraes
en Limba Engleză Paperback – 30 iun 2003
Provides a detailed look at opium today in the context of its long history of use as a therapeutic and recreational drug. Opium use dates back 7000 years—longer than any other drug. This book looks at social changes and how they have affected perceptions of opium. Dr. Thomas Sydenham wrote, "Among the remedies which it has pleased the Almighty God to give to man to relieve his sufferings, none is so universal and so efficacious as opium." From this gloving description of opium—written 325 years ago—to today, perceptions of opium have changed dramatically. Opium is now looked upon with fear more than anything else; along with its derivatives, opium is the most controlled drug in existence—some derivatives are unavailable even with a doctor's prescription.

The pharmacology and effects are discussed in non-technical terms. Drugs derived from opium, like heroin, and drugs created entirely in the lab, such as methadone, are explained.

The Little Book of Opium aids in "harm reduction" by providing useful information that can save lives of people using or experimenting with opium or its derivative. It will also help people better understand their medical treatment when faced with various
Citește tot Restrânge

Preț: 6909 lei

Nou

Puncte Express: 104

Preț estimativ în valută:
1322 1373$ 1098£

Carte tipărită la comandă

Livrare economică 03-17 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780914171836
ISBN-10: 0914171836
Pagini: 141
Ilustrații: 20 B&W illustrations
Dimensiuni: 151 x 205 x 10 mm
Greutate: 0.2 kg
Ediția:New.
Editura: Ronin Publishing (CA)
Seria Little Books (Ronin Publishing)


Descriere

Though few challenge the efficacy of opium as a pain reliever during its 7,000-year history, today it is feared more than revered. This book reviews its storied history and pharmacology in nontechnical terms, providing useful “harm reduction” information for those experimenting with the drug or its derivatives.